indazoles has been researched along with rabeprazole in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dalziel, G; Ding, X; Dresser, MJ; Fridyland, J; Holden, SN; Jin, JY; Morrisson, G; Pellett, JD; Salphati, L; Smelick, GS; Sutton, R; Ware, JA; West, DA | 1 |
Budha, N; Dalziel, G; Davis, JD; Fraczkiewicz, G; Jin, JY; Lu, T; Morrissey, KM; Salphati, L; Smelick, GS; Ware, JA | 1 |
2 trial(s) available for indazoles and rabeprazole
Article | Year |
---|---|
Impact of food and the proton pump inhibitor rabeprazole on the pharmacokinetics of GDC-0941 in healthy volunteers: bench to bedside investigation of pH-dependent solubility.
Topics: Antineoplastic Agents; Biological Availability; Cross-Over Studies; Food-Drug Interactions; Healthy Volunteers; Hydrogen-Ion Concentration; Indazoles; Proton Pump Inhibitors; Rabeprazole; Solubility; Sulfonamides | 2013 |
Combining "Bottom-up" and "Top-down" Approaches to Assess the Impact of Food and Gastric pH on Pictilisib (GDC-0941) Pharmacokinetics.
Topics: Administration, Oral; Anti-Ulcer Agents; Biological Availability; Computer Simulation; Cross-Over Studies; Diet, High-Fat; Female; Healthy Volunteers; Humans; Hydrogen-Ion Concentration; Indazoles; Intestines; Male; Models, Biological; Rabeprazole; Random Allocation; Sulfonamides | 2017 |